Drug intelligence / Profile preview

icodextrin + amino acids + bicarbonate + lactate

Development stage
Unknown
Lead developer
Takeda
Modality
Peptides, Small Molecules
Administration
Intraperitoneal
01

Overview

This combination regimen represents a 'biocompatible' strategy for peritoneal dialysis (PD), specifically utilized in continuous ambulatory peritoneal dialysis (CAPD) for patients with end-stage renal disease (ESRD). The regimen consists of several distinct solutions: icodextrin (a glucose polymer) used for long dwells to provide sustained ultrafiltration without high glucose exposure; amino acid-based solutions that serve as both an osmotic agent and a nutritional supplement; and solutions buffered with bicarbonate and lactate to maintain a physiological pH. By reducing exposure to high concentrations of glucose and glucose degradation products (GDPs), this multi-component approach aims to preserve the peritoneal membrane's integrity and the patient's residual renal function (RRF) more effectively than conventional, acidic, lactate-only glucose solutions.

Other names
biocompatible peritoneal dialysis solutionspoliglucose + amino acids + bicarbonate + lactatebiocompatible PD solutions

Beyond the preview

Go deeper on icodextrin + amino acids + bicarbonate + lactate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on icodextrin + amino acids + bicarbonate + lactate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call